Cullinan

$Cullinan(CGEM)$ 8-K Current report, items 2.02, 7.01, 8.01, and 9.01 Accession Number: 0001193125-26-006998  Act: 34  Size: 225 KB 网页链接

#药闻简讯# $Cullinan(CGEM)$ 公司获得 FDA 快速通道认定，用于 CLN-049，一种新型 FLT3xCD3 T 细胞嵌合抗原受体疗法

$Cullinan(CGEM)$ 这么棒的票值得继续关注

$Cullinan(CGEM)$12月1号 新闻 Cullinan Therapeutics 临床性急性髓系白血病治疗获得美国FDA快速通道认证 没反应 观察下 建点仓

$Cullinan(CGEM)$ 来了 我周五有买

$Cullinan(CGEM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-327033  Size: 5 KB 网页链接

$Cullinan(CGEM)$ 144 Report of proposed sale of securities Accession Number: 0001950047-25-010561  Act: 33  Size: 7 KB 网页链接

$Cullinan(CGEM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-002687  Size: 5 KB 网页链接

$Cullinan(CGEM)$ 144 Report of proposed sale of securities Accession Number: 0001950047-25-010308  Act: 33  Size: 5 KB 网页链接

$Cullinan(CGEM)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000902664-25-004966  Act: 34  Size: 11 KB 网页链接

$Cullinan(CGEM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-297549  Size: 4 KB 网页链接

$Cullinan(CGEM)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0000102909-26-000065  Act: 34  Size: 7 KB 网页链接

$Cullinan(CGEM)$ 8-K Current report, item 1.02 Accession Number: 0001193125-25-291448  Act: 34  Size: 145 KB 网页链接

$Cullinan(CGEM)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001104659-25-112463  Act: 34  Size: 18 KB 网页链接

$Cullinan(CGEM)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001193805-25-001585  Act: 34  Size: 16 KB 网页链接

$Cullinan(CGEM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-327027  Size: 4 KB 网页链接

$Cullinan(CGEM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-327030  Size: 4 KB 网页链接

$Cullinan(CGEM)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001193125-25-310764  Act: 34  Size: 245 KB 网页链接

$Cullinan(CGEM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-321122  Size: 6 KB 网页链接

$Cullinan(CGEM)$ Vanguard Group Inc. 报告称，截至2025年12月31日，持有Cullinan Therapeutics Inc. 3,298,504股受益所有权股份，占已发行股份的5.58%。此文件是对先前申报的修正，先前持股比例为0%。这些股份是在正常业务过程中获得的，并非旨在改变发行人的控制权。Vanguard Group, Inc.的客户...